Live · 03 Oct 2026 SPX 7,722.72 +0.73% NDX 30,807.93 +1.00% VIX 15.31 -6.59% GOLD 4,162.30 -0.95% CL 91.11 -1.90% BTC 84,850.88 +0.42%
NAS100 30,808 +1.00% S&P 7,723 +0.73% GOLD $4,162 −0.95% BTC $84,851 +0.42% VIX 15.31 −6.59% live tape · as of 19:05 UTC · 3 Oct
The Screen · ETF

Azzad Ethical Mid Cap Fund

ADJEX · MUTUAL FUND · USD

The fund seeks to achieve its objective by investing primarily in common stocks of mid-capitalization companies that the Adviser believes are high quality and/or exhibit above-average growth potential, which, for the pur…

PASS · Titan Ethical · score 30.0
17.59 USD

Screen close, 2026-09-21 · not a live quote
Last reviewed 13 days ago

Screened 2026-09-21 · the tape above runs as of 19:05 UTC · 3 Oct · two dates, stated on purpose · verdict and workings shown in full · never trimmed

PRICE · FAIR-VALUE RANGE1M3M6MYTD1Y3Y5Y

What this means: price 17.59 against the desk's fair-value range, over the last year.

Current read
Accumulation ?
OVERVALUED · screened 2026-09-21
  • Trend Accumulation
  • Insiders no filings inside 60 days, left as found
  • Positioning no disclosures inside 60 days, left as found
  • Options no verdict drawn today, left as found
  • Ethical passes the values gate
Price17.59 USD
Ethical score30.0/100
RatingOVERVALUED
Our investment reviews on this name
2026-09-19Read Markdown17.54+0.3% to today
2026-07-02Read Accumulation17.80-1.2% to today

Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.

The full research record, in depth, below
The Label · The Season, Not the Day

This name holds its accumulation label.

Azzad Ethical Mid Cap Fund holds its Accumulation at $17.59. The statistical read favours the sellers, held for 314 days.

As held on the ledger · 2026-09-21
PhaseAccumulation
Quantitative stateThe statistical read favours the sellers, held for 314 days
Price at the screen$17.59
Valuation37.14 trailing · N/A forward price to earnings
Values screenPASS · score 30.0
The Workings

Five Screens, Shown in Full

Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.

TestFigureLimitWhat it meansStatus
Business activity Excluded Core business clean Shariah-screened instrument — compliant by design Fail
Debt load Excluded Below 33% Interest-bearing debt is of its assets, above the one-third ceiling the screen allows. Fail
Interest-bearing cash Excluded Below 33% Interest-bearing cash and securities are of assets, above the one-third limit. Fail
Receivables Excluded Below 49% Money owed to the company is of assets, above the 49% limit. Fail
Revenue purity Excluded Below 5% of revenue comes from non-compliant sources, over the 5% line. Fail

Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.

The Ethical Read

Why It Clears, in Plain English

Azzad Ethical Mid Cap Fund clears all five screens. Its business is in a permissible area, its debt, cash, receivables and income are all inside the lines, so it passes.

Read as at 2026-10-03. It updates when the underlying figures move, and past reads are kept below.

What the Numbers Say It Is Worth

The Fair Value Range

Our framework reads OVERVALUED

Price History & Projections
$18.0$16.1$14.3TODAY5y agoPROJECTION

Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-21 screen.

Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.

The Business, in Plain Words
The fundamentals · plain-English read
Trailing P/E37.1xexpensive: the price assumes strong growth ahead
52-week range14.89 - 18.39

The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.

Plain-English interpretation of our own screen data. Analysis, not advice.

Where & How to Trade

ADJEX trades on MUTUAL FUND. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.

The Dated Journal · Newest First, Never Edited

Every Entry, As Written

2026-10-02 Markdown $17.59 +0.3% Entry 8

The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 0.3% since our last review. Ethical screening: PASS with ethical pass with moderate score. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are up 10%. Our forward projection puts the odds of a 10% gain over the next month near 9%.

2026-09-19 Markdown · changed $17.54 +0.0% Entry 7

The framework has shifted from accumulation to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with ethical pass with moderate score. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are up 10%. Our forward projection puts the odds of a 10% gain over the next month near 9%.

2026-08-20 Accumulation $17.54 +0.0% Entry 6

The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with ethical pass with moderate score. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are up 10%. Our forward projection puts the odds of a 10% gain over the next month near 9%.

2026-07-20 Accumulation $17.54 -1.5% Entry 5

The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 1.5% since our last review. Ethical screening: PASS with ethical pass with moderate score. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are up 10%. Our forward projection puts the odds of a 10% gain over the next month near 9%.

2026-07-18 Accumulation $17.80 +0.0% Entry 4

The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with ethical pass with moderate score. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are up 10%. Our forward projection puts the odds of a 10% gain over the next month near 9%.

2026-07-16 Accumulation $17.80 +0.0% Entry 3

The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with ethical pass with moderate score. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are up 10%. Our forward projection puts the odds of a 10% gain over the next month near 9%.

2026-07-03 Accumulation $17.80 +0.0% Entry 2

The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with ethical pass with moderate score. The risk-adjusted return profile shows modest positive risk-adjusted returns.

2026-07-02 Accumulation $17.80 Entry 1

The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Ethical screening: PASS with ethical pass with moderate score. The risk-adjusted return profile shows modest positive risk-adjusted returns.

Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.

What Holding Actually Paid · Price Plus Dividends
If $1,000 had been placed · historical, not a promise
PeriodPrice thenPrice returnDivs per share$1,000 becameTotal return
1 month $17.16 +3.2% · $1,032 +3.2%
2 months $15.88 +11.5% · $1,115 +11.5%
3 months $16.18 +9.4% · $1,094 +9.4%
6 months $16.84 +5.1% · $1,051 +5.1%
1 year $16.04 +10.4% · $1,104 +10.4%
2 years $16.31 +8.6% $0.88 $1,139 +13.9%
3 years $14.51 +22.0% $1.30 $1,309 +30.9%
5 years $15.77 +12.2% $3.74 $1,359 +35.9%

Historical returns from market close data. Past performance does not guarantee future results.

The Ledger's Promise

This entry now belongs to the ledger. Whatever ADJEX does next, these words stay.

Azzad Ethical Mid Cap Fund · ADJEX · Accumulation · $17.59
Recorded 2026-09-21 · before the outcome · scored mechanically

Membership

Thirteen thousand names carry this page. One desk keeps them honest.

Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.

Join the desk

Screening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.

Get our weekly market brief free.